Indium DTPA and Insulin glargine and lixisenatide Subcutaneous
Determining the interaction of Indium DTPA and Insulin glargine and lixisenatide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: indium pentetate in-111
Brand name:
Synonyms: Pentetate Indium Disodium In 111, In-111 DTPA
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Indium DTPA-Insulin glargine, recombinant Subcutaneous
- Indium DTPA-Insulin glulisine
- Indium DTPA-Insulin Glulisine (Cartridges and Pens)
- Indium DTPA-Insulin Glulisine (Vials)
- Indium DTPA-Insulin glulisine Subcutaneous
- Indium DTPA-Insulin human inhaled Inhalation
- Insulin glargine and lixisenatide Subcutaneous-Indium In-111 Pentetreotide
- Insulin glargine and lixisenatide Subcutaneous-Indium Oxyquinoline
- Insulin glargine and lixisenatide Subcutaneous-Indocid
- Insulin glargine and lixisenatide Subcutaneous-Indocin
- Insulin glargine and lixisenatide Subcutaneous-Indocin (Indomethacin Suppositories)
- Insulin glargine and lixisenatide Subcutaneous-Indocin (Indomethacin Suspension)